Mindblown: a blog about philosophy.
-
Singapore Girl Launches 30-Climate Travel Beauty System, Turning Destination Weather into Personalised Skincare
Singapore-born travel beauty brand Singapore Girl turns six temperature ranges and five humidity ranges into a 30-condition decision architecture for short trips. SINGAPORE – SEPTEMBER 14, 2026 – A traveller can leave warm, very humid Singapore and arrive hours later in an environment that is cold and dry, hot and arid, or somewhere in between. Yet…
-
Shanghai Droi Technology Unveils DroiClaw 3 and Wide-Format Agentic Smartphone at RMB 999
The new Coolpad device brings DroiClaw 3 to a wider 10:16 display, with China sales planned for October at RMB 999. Shanghai, September 14, 2026 — Shanghai Droi Technology has introduced what it describes as the world’s first wide-format smartphone built for agentic AI, alongside DroiClaw 3, its latest AI-native OS. The Coolpad device is…
-
Atrial Fibrillation Market Growth Outlook 2034: Epidemiology, Pipeline Therapies, and Revenue Forecast – DelveInsight | Anthos Therapeutics, ARCA biopharma, AbbVie, Espero BioPharma, Vivasc Therapeuti
(Albany, New York) – September 14, 2026: The Key Atrial Fibrillation Companies in the market include – Thryv Therapeutics Inc., Vivasc Therapeutics, Verseon, HUYA Bioscience, Novartis, AbbVie, Bayer AG, InCarda Therapeutics, Inc., and others . The Atrial Fibrillation market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period.…
-
The 48th WorldSkills Competition to Be Held in Shanghai, China
From the ancient spark to the light of the future, the torch of skills has never been extinguished! No matter where you are or what craft you master, you can become a shining star of skills. Skills change the world, and skills light up the future! Shanghai, China – September 14, 2026 – The 48th WorldSkills Competition…
-
COPD Pipeline 2026: Key Developments, Emerging Therapies, and Clinical Trials Detailed Analysis by DelveInsight | Amgen, Synairgen, AstraZeneca, Sanofi, Organicell Regenerative Medicine
(Albany, New York) – September 14, 2026 (Las Vegas, Nevada, United States): As per DelveInsight’s assessment, globally, Chronic Obstructive Pulmonary Disease pipeline constitutes 65+ key companies continuously working towards developing 75+ Chronic Obstructive Pulmonary Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Chronic Obstructive…
-
Whiskey Would Announces Midwest Touring Expansion as New Singles Gain Momentum
Columbus, OH, USA – September 14, 2026 – Modern country-rock breakout band Whiskey Would is officially expanding their footprint across the Midwest, launching a regional touring push aimed at reaching new audiences, strengthening industry visibility, and building momentum behind their latest singles. With a sound rooted in Country grit, Rock energy, Southern soul, and Blues…
-
Acquired Hemophilia A Clinical Trial Pipeline Gains Momentum: 10+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
The Acquired Hemophilia A clinical trial analysis report delivers important insights into ongoing research of 10+ pipeline Acquired Hemophilia A drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 11, 2026- DelveInsight’s “Acquired Hemophilia A Pipeline Insight, 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the Acquired Hemophilia…
-
Nonalcoholic Steatohepatitis Market Set to Witness Growth with Expanding Late-Stage Pipeline by 2034 – DelveInsight | Novo Nordisk, Madrigal Pharmaceuticals, 89bio, Akero Therapeutics
The Key Nonalcoholic Steatohepatitis Companies in the market include – Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Eli Lilly and Company, Madrigal Pharmaceuticals, Inc, Terns, Inc., Intercept Pharmaceuticals, Enyo Pharma, 89bio, Inc., Akero Therapeutics, Inc, and others. (Albany, US), September 11, 2026 – DelveInsight’s report “Nonalcoholic Steatohepatitis Diagnostics Market Insights, Epidemiology, and Market Forecast-2034” provides…
-
Migraine Market: Pharma Pipeline Fuels Rapid Expansion by 2036 – DelveInsight | Eli Lilly, Teva Pharma, Axsome Therapeutics, AEON Biopharma, Charleston Lab, Amgen, Teva Pharma, Anne Lindblad
The Key Migraine Companies in the market include – Eli Lilly and Company, Teva Pharmaceuticals, Axsome Therapeutics, AEON Biopharma, Inc., Charleston Laboratories, Amgen, Teva Pharmaceuticals, Eli Lilly and Company, Anne Lindblad, Allergan, AbbVie, Tian Medical Inc., Allergan, H. Lundbeck A/S, Tonix Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., and others . The Migraine market is expected to…
-
Chronic Hepatitis B Market Statistics Expected to Experience Major Growth by 2034, According to DelveInsight | Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Precision Biosciences, Silverback Thera
The Key Chronic Hepatitis B Companies in the market include – Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Precision Biosciences, Silverback Therapeutics, GSK, Drug Farm, Arbutus bio, Dicerna Pharmaceuticals, Roche, Ligand Pharmaceuticals, Dong-A ST Co., Vir Biotechnology, Arbutus Biopharma, and others. (Albany, New York) – September 11, 2026: DelveInsight’s “Chronic Hepatitis B Market Insights, Epidemiology, and Market…
Got any book recommendations?